FB2026_02 , released June 18, 2026
FB2026_02 , released June 18, 2026
Allele: Scer\GAL4l(2)GSG317-GSG317
Open Close
General Information
Symbol
Scer\GAL4l(2)GSG317-GSG317
Species
S. cerevisiae
Name
FlyBase ID
FBal0220203
Feature type
allele
Associated gene
Scer\GAL4
Associated Insertion(s)
P{Switch2}l(2)GSG317GSG317
Carried in Construct
Genomic Maps

Allele class
Mutagen
    Nature of the Allele
    Allele class
    Mutagen
    Progenitor genotype
    Associated Insertion(s)
    P{Switch2}l(2)GSG317GSG317
    Cytology
    Description
    Allele components
    Component
    Use(s)
    Inserted element
    P{Switch2}
    Encoded product / tool
    GAL4::GS
    Mutations Mapped to the Genome
    Curation Data
    Variant Molecular Consequences
    Associated Sequence Data
    DDBJ / EMBL / GenBank
    DNA sequence
    Protein sequence
     
    UniProtKB/Swiss-Prot
      UniProtKB/TrEMBL
        Expression Data
        Reporter Expression
        distribution deduced from reporter (Gal4 UAS)
        Stage
        Tissue/Position (including subcellular localization)
        Reference
        third instar larval stage
        larval ventral nerve cord | restricted | segmentally repeated
        (Nicholson et al., 2008)
        larval neuron | subset
        (Nicholson et al., 2008)
        larval glial cell | subset
        (Nicholson et al., 2008)
        intermediate longitudinal fascicle
        (Nicholson et al., 2008)
        lateral longitudinal fascicle
        (Nicholson et al., 2008)
        medial longitudinal fascicle
        (Nicholson et al., 2008)
        VL fascicle
        (Nicholson et al., 2008)
        CNS surface glial cell of larval ventral nerve cord
        (Nicholson et al., 2008)
        Additional Information
        Statement
        Reference

        ScerGAL4l(2)GSG317-GSG317 drives mifepristone-inducible expression primarily in a subset of neurons and glial cells. Weak expression is obseved in ~5 lateral and ~5 ventral cells/hemisegment in the ventral nerve cord. Expression is observed in intersegmental processes in central, medial, and lateral longitudinal tracts, and a ventral lateral longitudinal axon tract (likely FasII VL axon tract). Strong expression is observed in CNS surface glia over the ventral nerve cord, but not over the brain.

        (Nicholson et al., 2008)
         
        Marker for
        Reflects expression of
        Reporter construct used in assay
        Human Disease Associations
        Disease Ontology (DO) Annotations
        Models Based on Experimental Evidence ( 0 )
        Disease
        Evidence
        References
        Modifiers Based on Experimental Evidence ( 0 )
        Disease
        Interaction
        References
        Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
         
        Disease-implicated variant(s)
         
        Phenotypic Data
        Phenotypic Class
        Phenotype Manifest In
        Detailed Description
        Statement
        Reference
        External Data
        Interactions
        Show genetic interaction network for Enhancers & Suppressors
        Phenotypic Class
        Phenotype Manifest In
        Additional Comments
        Genetic Interactions
        Statement
        Reference
        Xenogenetic Interactions
        Statement
        Reference
        Complementation and Rescue Data
        Comments
        Images (0)
        Mutant
        Wild-type
        Stocks (1)
        Notes on Origin
        Discoverer
        External Crossreferences and Linkouts ( 0 )
        Synonyms and Secondary IDs (1)
        Reported As
        Symbol Synonym
        Scer\GAL4l(2)GSG317-GSG317
        Name Synonyms
        Secondary FlyBase IDs
          References (2)